BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 11839727)

  • 1. Gut adaptation and the glucagon-like peptides.
    Drucker DJ
    Gut; 2002 Mar; 50(3):428-35. PubMed ID: 11839727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minireview: the glucagon-like peptides.
    Drucker DJ
    Endocrinology; 2001 Feb; 142(2):521-7. PubMed ID: 11159819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological actions and therapeutic potential of the glucagon-like peptides.
    Drucker DJ
    Gastroenterology; 2002 Feb; 122(2):531-44. PubMed ID: 11832466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glucagon-like peptides--synthesis, biological actions and some clinical implications].
    Otto Buczkowska E; Dworzecki T
    Przegl Lek; 2004; 61(9):947-50. PubMed ID: 15803906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2.
    Drucker DJ; Lovshin J; Baggio L; Nian M; Adatia F; Boushey RP; Liu Y; Saleh J; Yusta B; Scrocchi L
    Ann N Y Acad Sci; 2000; 921():226-32. PubMed ID: 11193827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system.
    Brubaker PL; Drucker DJ
    Endocrinology; 2004 Jun; 145(6):2653-9. PubMed ID: 15044356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
    Drucker DJ
    Mol Endocrinol; 2003 Feb; 17(2):161-71. PubMed ID: 12554744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2.
    Baggio LL; Drucker DJ
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):531-54. PubMed ID: 15533774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptides.
    Drucker DJ
    Diabetes; 1998 Feb; 47(2):159-69. PubMed ID: 9519708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is glucagon-like peptide 1 an incretin hormone?
    Nauck MA
    Diabetologia; 1999 Mar; 42(3):373-9. PubMed ID: 10096792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide 2 function in domestic animals.
    Burrin DG; Stoll B; Guan X
    Domest Anim Endocrinol; 2003 Mar; 24(2):103-22. PubMed ID: 12586312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator.
    Thulesen J
    Curr Protein Pept Sci; 2004 Feb; 5(1):51-65. PubMed ID: 14965320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1.
    Nagell CF; Wettergren A; Pedersen JF; Mortensen D; Holst JJ
    Scand J Gastroenterol; 2004 Apr; 39(4):353-8. PubMed ID: 15125467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide 2.
    Drucker DJ
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1759-64. PubMed ID: 11297614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut hormones as pharmaceuticals. From enteroglucagon to GLP-1 and GLP-2.
    Holst JJ
    Regul Pept; 2000 Sep; 93(1-3):45-51. PubMed ID: 11033052
    [No Abstract]   [Full Text] [Related]  

  • 16. Proglucagon-derived peptides: mechanisms of action and therapeutic potential.
    Sinclair EM; Drucker DJ
    Physiology (Bethesda); 2005 Oct; 20():357-65. PubMed ID: 16174875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between gastric emptying and satiety, with special reference to glucagon-like peptide-1.
    Hellström PM; Näslund E
    Physiol Behav; 2001; 74(4-5):735-41. PubMed ID: 11790437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice.
    Shin ED; Estall JL; Izzo A; Drucker DJ; Brubaker PL
    Gastroenterology; 2005 May; 128(5):1340-53. PubMed ID: 15887116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteroendocrine-derived glucagon-like peptide-2 controls intestinal amino acid transport.
    Lee J; Koehler J; Yusta B; Bahrami J; Matthews D; Rafii M; Pencharz PB; Drucker DJ
    Mol Metab; 2017 Mar; 6(3):245-255. PubMed ID: 28271031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide 2 is a potent growth factor for small intestine and colon.
    Litvak DA; Hellmich MR; Evers BM; Banker NA; Townsend CM
    J Gastrointest Surg; 1998; 2(2):146-50. PubMed ID: 9834410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.